XTNT Key Statistics, Chart & Performance
The current stock price of XTNT is 0.595 USD. In the past month the price decreased by -32.86%. In the past year, price increased by 46.09%.
XTNT Latest News, Press Relases and Analysis
XTNT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 18.84 | 15.05B | ||
| SOLV | SOLVENTUM CORP | 14.46 | 14.89B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.46 | 10.73B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.6 | 4.99B | ||
| LNTH | LANTHEUS HOLDINGS INC | 9.77 | 3.86B | ||
| HAE | HAEMONETICS CORP/MASS | 16.74 | 3.76B | ||
| ICUI | ICU MEDICAL INC | 18.35 | 3.61B | ||
| XRAY | DENTSPLY SIRONA INC | 7 | 2.21B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.69 | 1.71B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.29B | ||
| NEOG | NEOGEN CORP | 19.7 | 1.28B | ||
| EMBC | EMBECTA CORP | 4.14 | 718.84M |
Related stock screener links
About XTNT
Company Profile
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
Company Info
XTANT MEDICAL HOLDINGS INC
664 Cruiser Lane
Belgrade Montana MONTANA 59714 US
CEO: Sean E. Browne
Employees: 217
Phone: 14063880480
XTANT MEDICAL HOLDINGS INC / XTNT FAQ
What does XTNT do?
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
What is the stock price of XTANT MEDICAL HOLDINGS INC today?
The current stock price of XTNT is 0.595 USD. The price increased by 0.76% in the last trading session.
Does XTANT MEDICAL HOLDINGS INC pay dividends?
XTNT does not pay a dividend.
What is the ChartMill rating of XTANT MEDICAL HOLDINGS INC stock?
XTNT has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the market cap for XTANT MEDICAL HOLDINGS INC?
XTANT MEDICAL HOLDINGS INC (XTNT) has a market capitalization of 83.30M USD. This makes XTNT a Micro Cap stock.
When does XTANT MEDICAL HOLDINGS INC (XTNT) report earnings?
XTANT MEDICAL HOLDINGS INC (XTNT) will report earnings on 2026-03-04, before the market open.
What is the ownership structure of XTANT MEDICAL HOLDINGS INC (XTNT)?
You can find the ownership structure of XTANT MEDICAL HOLDINGS INC (XTNT) on the Ownership tab.
XTNT Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to XTNT. When comparing the yearly performance of all stocks, XTNT is one of the better performing stocks in the market, outperforming 85.88% of all stocks.
XTNT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to XTNT. Both the profitability and financial health of XTNT have multiple concerns.
XTNT Financial Highlights
Over the last trailing twelve months XTNT reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS increased by 107.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.43% | ||
| ROE | -9.44% | ||
| Debt/Equity | 0.46 |
XTNT Forecast & Estimates
8 analysts have analysed XTNT and the average price target is 1.53 USD. This implies a price increase of 157.14% is expected in the next year compared to the current price of 0.595.
For the next year, analysts expect an EPS growth of 108.5% and a revenue growth 10.6% for XTNT